Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Nanobiotechnology|September 19, 2022
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancerYun Hu, Sébastien Paris, Genevieve Bertolet, et al.Journal of Nanobiotechnology|October 1, 2024
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3Yun Hu, Sébastien Paris, Narayan Sahoo, et al.Cancer Immunology Research|January 26, 2023
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung CancerKewen He, Hampartsoum B Barsoumian, Nahum Puebla-Osorio, et al.Frontiers in Immunology|November 21, 2022
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer modelYun Hu, Sébastien Paris, Genevieve Bertolet, et al.Journal for Immunotherapy of Cancer|October 27, 2020
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stromaHampartsoum B Barsoumian, Rishab Ramapriyan, Ahmed I Younes, et al.JCI Insight|June 22, 2023
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejectionYun Hu, Sébastien Paris, Narayan Sahoo, et al.Frontiers in Oncology|October 24, 2024
Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapyNahum Puebla-Osorio, Natalie Wall Fowlkes, Hampartsoum B Barsoumian, et al.Cancer Discovery|September 11, 2012
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1Lauren Averett Byers, Jing Wang, Monique B Nilsson, et al.Molecular Cancer|February 3, 2025
Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteinsMaria Angelica Freitas-Cortez, Fatemeh Masrorpour, Hong Jiang, et al.Pageof 2